Arcutis Biotherapeutics Insider Sale EVP and CMO Burnett Disposes of 4673 in Common Stock CareDx CDNA Reports Strong Q1 2026 Revenue NA EPS Beats Equity EQR Stalls at 6559 Consolidation Phase 20260514